Literature DB >> 18175065

Chronic kidney disease perspectives in Japan and the importance of urinalysis screening.

Kunihiro Yamagata1, Kunitoshi Iseki, Kousaku Nitta, Hirokazu Imai, Yasuhiko Iino, Seiichi Matsuo, Hirofumi Makino, Akira Hishida.   

Abstract

There are racial differences in primary renal diseases for end-stage renal disease (ESRD) and the incidence and prevalence of cardiovascular disease (CVD). To reduce the number of patients with both ESRD and CVD, an effective screening method for CKD should be established. In Japan, screening with the urine dip-stick test for proteinuria has been used since 1972 targeting every child and worker and since 1983 for every resident over 40 years old. There are several reasons for continuing this screening program. First, the positive rate of proteinuria is high in the Japanese general population, especially subjects with neither hypertension nor diabetes. Most of these subjects have no symptoms, and the only sign of renal disease is asymptomatic urinary abnormalities. Second, the prevalence and incidence of glomerulonephritis, especially IgA nephropathy, are high in the Japanese and Asian races, and urinalysis is the only method for early detection of chronic glomerulonephritis. Third, 10-year survival of the ESRD patients due to glomerulonephritis was approximately twice that of ESRD patients due to diabetes and nephrosclerosis. Consequently, reducing the incidence of ESRD due to glomerulonephritis is one of the best ways to reduce the prevalence of ESRD. Furthermore, higher incidence of ESRD in Asian races than in Caucasians was reported. Proteinuria is known to be the best predictor for reducing renal function, and the urine dip-stick test for proteinuria is less expensive and is cost-effective. For an effective screening strategy to reduce the ESRD population in Japanese and Asians, universal screening with the urine dip-stick test for proteinuria could be one solution.

Entities:  

Mesh:

Year:  2008        PMID: 18175065     DOI: 10.1007/s10157-007-0010-9

Source DB:  PubMed          Journal:  Clin Exp Nephrol        ISSN: 1342-1751            Impact factor:   2.801


  73 in total

1.  Albuminuria as early test for vascular disease.

Authors:  Giuseppe Remuzzi; Jan J Weening
Journal:  Lancet       Date:  2005 Feb 12-18       Impact factor: 79.321

2.  Prevalence and risk factor analysis of microalbuminuria in Japanese general population: the Takahata study.

Authors:  T Konta; Z Hao; H Abiko; M Ishikawa; T Takahashi; A Ikeda; K Ichikawa; S Takasaki; I Kubota
Journal:  Kidney Int       Date:  2006-08       Impact factor: 10.612

3.  Racial differences in trends of end-stage renal disease, by primary diagnosis--United States, 1994-2004.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2007-03-23       Impact factor: 17.586

4.  Prognosis of asymptomatic hematuria and/or proteinuria in men. High prevalence of IgA nephropathy among proteinuric patients found in mass screening.

Authors:  Kunihiro Yamagata; Hideto Takahashi; Chie Tomida; Yoh Yamagata; Akio Koyama
Journal:  Nephron       Date:  2002-05       Impact factor: 2.847

5.  Chronic renal diseases as a public health problem: epidemiology, social, and economic implications.

Authors:  Arrigo Schieppati; Giuseppe Remuzzi
Journal:  Kidney Int Suppl       Date:  2005-09       Impact factor: 10.545

6.  Proteinuria screening for children.

Authors:  Mutsumi Murakami; Mari Hayakawa; Tsuyoshi Yanagihara; Yoshitaka Hukunaga
Journal:  Kidney Int Suppl       Date:  2005-04       Impact factor: 10.545

7.  Controlling the epidemic of cardiovascular disease in chronic renal disease: what do we know? What do we need to learn? Where do we go from here? National Kidney Foundation Task Force on Cardiovascular Disease.

Authors:  A S Levey; J A Beto; B E Coronado; G Eknoyan; R N Foley; B L Kasiske; M J Klag; L U Mailloux; C L Manske; K B Meyer; P S Parfrey; M A Pfeffer; N K Wenger; P W Wilson; J T Wright
Journal:  Am J Kidney Dis       Date:  1998-11       Impact factor: 8.860

Review 8.  The burden of kidney disease: improving global outcomes.

Authors:  Garabed Eknoyan; Norbert Lameire; Rashad Barsoum; Kai-Uwe Eckardt; Adeera Levin; Nathan Levin; Francesco Locatelli; Alison MacLeod; Raymond Vanholder; Rowan Walker; Haiyan Wang
Journal:  Kidney Int       Date:  2004-10       Impact factor: 10.612

9.  Proteinuria and the risk of developing end-stage renal disease.

Authors:  Kunitoshi Iseki; Yoshiharu Ikemiya; Chiho Iseki; Shuichi Takishita
Journal:  Kidney Int       Date:  2003-04       Impact factor: 10.612

10.  Epidemiology of primary glomerular diseases in a French region. Variations according to period and age.

Authors:  P Simon; M P Ramée; V Autuly; E Laruelle; C Charasse; G Cam; K S Ang
Journal:  Kidney Int       Date:  1994-10       Impact factor: 10.612

View more
  48 in total

1.  Cost-effectiveness of chronic kidney disease mass screening test in Japan.

Authors:  Masahide Kondo; Kunihiro Yamagata; Shu-ling Hoshi; Chie Saito; Koichi Asahi; Toshiki Moriyama; Kazuhiko Tsuruya; Hideaki Yoshida; Kunitoshi Iseki; Tsuyoshi Watanabe
Journal:  Clin Exp Nephrol       Date:  2011-12-14       Impact factor: 2.801

2.  Report of the Asian Forum of Chronic Kidney Disease Initiative (AFCKDI) 2007. "Current status and perspective of CKD in Asia": diversity and specificity among Asian countries.

Authors:  Yusuke Tsukamoto; HaiYan Wang; Gavin Becker; Hung-Chun Chen; Dae-Suk Han; David Harris; Enyu Imai; Vivekanand Jha; Philip K T Li; Evan J C Lee; Seiichi Matsuo; Yasuhiko Tomino; Kriang Tungsanga; Kunihiro Yamagata; Akira Hishida
Journal:  Clin Exp Nephrol       Date:  2009-03-14       Impact factor: 2.801

3.  Diabetic kidney disease: act now or pay later.

Authors:  Robert C Atkins; Paul Zimmet
Journal:  Pediatr Nephrol       Date:  2009-12-15       Impact factor: 3.714

4.  Aichi cohort study of the prognosis in patients newly initiated into dialysis (AICOPP): baseline characteristics and trends observed in diabetic nephropathy.

Authors:  Manabu Hishida; Hirofumi Tamai; Takatoshi Morinaga; Michitaka Maekawa; Takafumi Aoki; Hidetaka Tomida; Shintaro Komatsu; Tomoaki Kamiya; Shoichi Maruyama; Seiichi Matsuo; Daijo Inaguma
Journal:  Clin Exp Nephrol       Date:  2016-02-23       Impact factor: 2.801

5.  Study on the relationship between Chinese medicine constitutive susceptibility and diversity of syndrome in diabetic nephropathy.

Authors:  Xin Mou; Di-yi Zhou; Wen-hong Liu; Dan-yang Zhou; Ying-hui Liu; Yong-bin Hu; Cheng-min Shou; Jia-wei Chen; Jin-xi Zhao; Guo-ling Ma
Journal:  Chin J Integr Med       Date:  2013-04-10       Impact factor: 1.978

6.  Chronic kidney disease prevention--a challenge for Asian countries: report of the Third Asian Forum of Chronic Kidney Disease Initiatives.

Authors:  Jer-Ming Chang; Shang-Jyh Hwang; Yusuke Tsukamoto; Hung-Chun Chen
Journal:  Clin Exp Nephrol       Date:  2012-03-03       Impact factor: 2.801

Review 7.  Steroid therapy in children with IgA nephropathy.

Authors:  Alexandra Cambier; Olivia Boyer; Georges Deschenes; James Gleeson; Anne Couderc; Julien Hogan; Thomas Robert
Journal:  Pediatr Nephrol       Date:  2019-02-18       Impact factor: 3.714

8.  Association of ELMO1 gene polymorphisms with diabetic nephropathy in Chinese population.

Authors:  H Y Wu; Y H Wu; Y Wang; M Chen; X Zhang; D Wang; Y Pan; L Li; D Liu; X M Dai; M X Dai
Journal:  J Endocrinol Invest       Date:  2012-07-24       Impact factor: 4.256

9.  Heart rate as a risk factor for developing chronic kidney disease: longitudinal analysis of a screened cohort.

Authors:  Taku Inoue; Kunitoshi Iseki; Chiho Iseki; Yusuke Ohya; Kozen Kinjo; Shuichi Takishita
Journal:  Clin Exp Nephrol       Date:  2009-05-15       Impact factor: 2.801

10.  Serofendic acid protects from iodinated contrast medium and high glucose probably against superoxide production in LLC-PK1 cells.

Authors:  Osamu Kitamura; Kazuhide Uemura; Hisayo Kitamura; Hachiro Sugimoto; Akinori Akaike; Takahiko Ono
Journal:  Clin Exp Nephrol       Date:  2008-10-01       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.